Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations.
Clin Cancer Res. 2023 Jun 1;29(11):2123-2130. doi: 10.1158/1078-0432.CCR-22-3497.
Clin Cancer Res. 2023.
PMID: 36913537
Free PMC article.
The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma.
Truini A, Starrett JH, Stewart T, Ashtekar K, Walther Z, Wurtz A, Lu D, Park JH, DeVeaux M, Song X, Gettinger S, Zelterman D, Lemmon MA, Goldberg SB, Politi K.
Truini A, et al. Among authors: starrett jh.
Clin Cancer Res. 2019 Nov 1;25(21):6382-6391. doi: 10.1158/1078-0432.CCR-19-0780. Epub 2019 Jun 10.
Clin Cancer Res. 2019.
PMID: 31182434
Free PMC article.
Item in Clipboard
Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations.
Starrett JH, Guernet AA, Cuomo ME, Poels KE, van Alderwerelt van Rosenburgh IK, Nagelberg A, Farnsworth D, Price KS, Khan H, Ashtekar KD, Gaefele M, Ayeni D, Stewart TF, Kuhlmann A, Kaech SM, Unni AM, Homer R, Lockwood WW, Michor F, Goldberg SB, Lemmon MA, Smith PD, Cross DAE, Politi K.
Starrett JH, et al.
Cancer Res. 2020 May 15;80(10):2017-2030. doi: 10.1158/0008-5472.CAN-19-3819. Epub 2020 Mar 19.
Cancer Res. 2020.
PMID: 32193290
Free PMC article.
Item in Clipboard
Preclinical Models for the Study of Lung Cancer Pathogenesis and Therapy Development.
Arnal-Estapé A, Foggetti G, Starrett JH, Nguyen DX, Politi K.
Arnal-Estapé A, et al. Among authors: starrett jh.
Cold Spring Harb Perspect Med. 2021 Dec 1;11(12):a037820. doi: 10.1101/cshperspect.a037820.
Cold Spring Harb Perspect Med. 2021.
PMID: 34518338
Free PMC article.
Review.
Item in Clipboard
Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC.
Tu E, McGlinchey K, Wang J, Martin P, Ching SL, Floc'h N, Kurasawa J, Starrett JH, Lazdun Y, Wetzel L, Nuttall B, Ng FS, Coffman KT, Smith PD, Politi K, Cooper ZA, Streicher K.
Tu E, et al. Among authors: starrett jh.
JCI Insight. 2022 Feb 8;7(3):e142843. doi: 10.1172/jci.insight.142843.
JCI Insight. 2022.
PMID: 35132961
Free PMC article.
Item in Clipboard
Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer.
Bartolacci C, Andreani C, Vale G, Berto S, Melegari M, Crouch AC, Baluya DL, Kemble G, Hodges K, Starrett J, Politi K, Starnes SL, Lorenzini D, Raso MG, Solis Soto LM, Behrens C, Kadara H, Gao B, Wistuba II, Minna JD, McDonald JG, Scaglioni PP.
Bartolacci C, et al.
Nat Commun. 2022 Jul 26;13(1):4327. doi: 10.1038/s41467-022-31963-4.
Nat Commun. 2022.
PMID: 35882862
Free PMC article.
Item in Clipboard
Author Correction: Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer.
Bartolacci C, Andreani C, Vale G, Berto S, Melegari M, Crouch AC, Baluya DL, Kemble G, Hodges K, Starrett J, Politi K, Starnes SL, Lorenzini D, Raso MG, Solis Soto LM, Behrens C, Kadara H, Gao B, Wistuba II, Minna JD, McDonald JG, Scaglioni PP.
Bartolacci C, et al.
Nat Commun. 2022 Aug 8;13(1):4640. doi: 10.1038/s41467-022-32459-x.
Nat Commun. 2022.
PMID: 35941179
Free PMC article.
No abstract available.
Item in Clipboard
Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and Achondroplasia.
Hudkins RL, Allen E, Balcer A, Hoffman ID, Iyer S, Neal M, Nelson KJ, Rideout M, Ye Q, Starrett JH, Patel P, Harris T, Swanson RV, Bensen DC.
Hudkins RL, et al. Among authors: starrett jh.
J Med Chem. 2024 Sep 26;67(18):16737-16756. doi: 10.1021/acs.jmedchem.4c01531. Epub 2024 Sep 11.
J Med Chem. 2024.
PMID: 39258897
Item in Clipboard
Cite
Cite